Sexual inactivity results in reversible reduction of LH bioavailability

International Journal of Impotence Research

Volumn 14, Issue 2, 2002, Pages 93-100

  Carosa, E ^a   Benvenga, S ^b   Trimarchi, F ^b   Lenzi, A ^c   Pepe, M ^c   Simonelli, C ^c   Jannini, E A ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Erectile dysfunction; Hypogonadism; Impotence; LH bioassay

Indexed keywords

HYPOPHYSIS HORMONE; LUTEINIZING HORMONE; TESTOSTERONE;

ADULT; ARTICLE; BIOAVAILABILITY; COHORT ANALYSIS; CONTROLLED STUDY; DRUG ACTIVITY; ERECTILE DYSFUNCTION; HORMONAL THERAPY; HORMONE ACTION; HORMONE DETERMINATION; HUMAN; HYPOGONADISM; HYPOTHALAMUS; IMMUNOREACTIVITY; IMPOTENCE; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; OUTCOMES RESEARCH; PRIORITY JOURNAL; SEXUAL BEHAVIOR; SEXUAL INTERCOURSE; TESTOSTERONE BLOOD LEVEL;

ADULT; AGED; COHORT STUDIES; COITUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMPOTENCE; LUTEINIZING HORMONE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUESTIONNAIRES;

EID: 0036242238     PISSN: 09559930     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj/ijir/3900832     Document Type: Article

References (35)

1. NIH consensus development panel on impotence
2. Impotence and its medical and psychological correlates: Results of the Massachusetts Male Aging Study
3. Impotence
4. A pill for impotence. Editorial
5. Endocrine screening for sexual dysfunction using free testosterone determinations
6. Is routine endocrine testing of impotent men necessary?
7. Lack of sexual activity from erectile dysfunction is associated with a reversible reduction in serum testosterone
8. Effects of luteinizing hormone-releasing hormone (LHRH) upon bioactive and immunoreactive serum LH levels in normal subjects
9. Bioactive luteinizing hormone pituitary reserves during normal and abnormal male puberty
10. Increased bioactive luteinizing hormone levels and Bio/Immuno ratio in women with hyperthecosis of the ovaries: Possible role of hyperinsulinemia
11. Gonadotropic hormones: Biosynthesis, secretion, receptors, and action
12. Endorphins in male impotence: Evidence for naltrexone stimulation of erectile activity in patient therapy
13. Affective and psychological response patterns: The effect of instructions on sexually functional and dysfunctional men
14. Advances in the understanding and management of erectile dysfunction
15. In vitro bioassay of LH in human serum: The rat interstitial cell testosterone (RICT) assay
16. WF. Bio- and immunoreactive luteinizing hormone responses to low doses of gonadotropin-releasing hormone (GnRH): Dose-response curves in GnRH-deficient men
17. Low bioactive luteinizing hormone in nonorganic male impotence: Possible relationship with altered gonadotropin-releasing hormone
18. Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction
19. The Medical Urethral System for Erection (MUSE) Study Group Treatment of men with erectile dysfunction with transurethral alprostadil
20. Yohimbine for male sexual dysfunction
21. Vascular reconstructive surgery in the management of erectile dysfunction
22. Venous surgery in erectile dysfunction
23. The use of penile prostheses in erectile dysfunction
24. The negative pressure device for erectile disorders: When does it fail?
25. Measurement of hormones
26. Preferential release of bioactive luteinizing hormone in response to endogenous and low dose exogenous gonadotropin-releasing hormone pulses in man
27. The GnRH family of peptides
28. Erectile function and naltrexone
29. Treatment of idiopathic erectile dysfunction in men with the opiate antagonist naltrexone - A double-blind study
30. Role of endogenous opiates in the expression of negative feedback actions of androgen and estrogen on pulsatile properties of luteinizing hormone secretion in man
31. Constancy of opioid control of luteinizing hormone in different pathophysiological states
32. Impotence associated with low biological to immunological ratio of luteinizing hormone in a man with a pituitary stone
33. Effects of aging and illness on the pituitary-testicular axis in men: Qualitative as well as quantitative changes in luteinizing hormone
34. Changes in the bioactivity to immunoreactivity ratio of circulating luteinizing hormone in impotent men treated with testosterone undecanoate